# Monitoring Outpatient Blood VolumE in Heart Failure

> **NCT04660396** · — · COMPLETED · sponsor: **Daxor Corporation** · enrollment: 15 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** BVA-100

## Key facts

- **NCT ID:** NCT04660396
- **Lead sponsor:** Daxor Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660396, "Monitoring Outpatient Blood VolumE in Heart Failure". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04660396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*